TCL Archive DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million February 27, 1987
TCL Archive Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival January 31, 2014
TCL Archive Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer February 25, 2011
TCL Archive Congressional News: Senate Subcommittee Recommends $2.3 Bil. Budget for NCI September 13, 1996